Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

September 6, 2025 | Presentation
Ultrasensitive MRD improves detection in resectable stage I NSCLC
ASCO
September 2, 2025 | Manuscript
Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial
Nature Communications
August 26, 2025 | Manuscript
Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma
Journal of Clinical Oncology
June 20, 2025 | Poster
Prognostic value of circulating tumor DNA (ctDNA) detection by PhasED-Seq after axicabtagene ciloleucel therapy in relapsed/refractory large B-cell lymphoma
EHA
June 3, 2025 | Poster
Safety and Efficacy of AZD0486, a CD19xCD3 T-cell Engager, in Relapsed or Refractory Diffuse Large B-cell Lymphoma
ASH
June 3, 2025 | Poster
Circulating tumor DNA assessment in patients with early-stage classical Hodgkin lymphoma treated with combination of brentuximab vedotin and nivolumab
ASCO